NASDAQ: PCVX
Vaxcyte Inc Stock Forecast, Predictions & Price Target

Analyst price target for PCVX

Based on 1 analyst offering 12 month price targets for Vaxcyte Inc

Min Forecast
$38.00-11.32%
Avg Forecast
$38.00-11.32%
Max Forecast
$38.00-11.32%

Should I buy or sell PCVX stock?

Based on 1 analyst offering ratings for Vaxcyte Inc.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although PCVX's forecast from analysts indicates a "Hold", our proven Zen Rating quant model rates PCVX as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -8.02% per year. Learn More

Be the first to know when Wall Street analysts revise their PCVX stock forecasts and price targets.

PCVX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-09-12

1 of 1

Forecast return on equity

Is PCVX forecast to generate an efficient return?

Company
-29.04%
Industry
94.29%
Market
-65.75%
PCVX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PCVX forecast to generate an efficient return on assets?

Company
-26.98%
Industry
36.43%
PCVX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PCVX earnings per share forecast

What is PCVX's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$5.19
Avg 2 year Forecast
-$5.82
Avg 3 year Forecast
-$7.07

PCVX revenue forecast

What is PCVX's revenue in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$150.0M
Avg 2 year Forecast
$14.3M
Avg 3 year Forecast
$216.0M

PCVX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PCVX$42.85$38.00-11.32%Hold
MTSR$52.52$58.50+11.39%Strong Buy
KRYS$188.05$195.57+4.00%Strong Buy
TGTX$34.14$57.50+68.42%Strong Buy
RNA$48.13$68.85+43.04%Strong Buy

Vaxcyte Stock Forecast FAQ

Is Vaxcyte Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: PCVX) stock is to Hold PCVX stock.

Out of 1 analyst, 0 (0%) are recommending PCVX as a Strong Buy, 0 (0%) are recommending PCVX as a Buy, 1 (100%) are recommending PCVX as a Hold, 0 (0%) are recommending PCVX as a Sell, and 0 (0%) are recommending PCVX as a Strong Sell.

If you're new to stock investing, here's how to buy Vaxcyte stock.

What is PCVX's earnings growth forecast for 2025-2027?

(NASDAQ: PCVX) Vaxcyte's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 4.79%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.38%.

Vaxcyte's earnings in 2025 is -$547,495,000.On average, 4 Wall Street analysts forecast PCVX's earnings for 2025 to be -$673,458,654, with the lowest PCVX earnings forecast at -$773,747,196, and the highest PCVX earnings forecast at -$563,433,361. On average, 4 Wall Street analysts forecast PCVX's earnings for 2026 to be -$755,247,368, with the lowest PCVX earnings forecast at -$945,114,024, and the highest PCVX earnings forecast at -$540,065,157.

In 2027, PCVX is forecast to generate -$917,851,120 in earnings, with the lowest earnings forecast at -$917,851,120 and the highest earnings forecast at -$917,851,120.

What is PCVX's revenue growth forecast for 2026-2028?

(NASDAQ: PCVX) Vaxcyte's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 88.41%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.64%.

Vaxcyte's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast PCVX's revenue for 2026 to be $19,473,503,250, with the lowest PCVX revenue forecast at $19,473,503,250, and the highest PCVX revenue forecast at $19,473,503,250. On average, 1 Wall Street analysts forecast PCVX's revenue for 2027 to be $1,856,473,977, with the lowest PCVX revenue forecast at $1,856,473,977, and the highest PCVX revenue forecast at $1,856,473,977.

In 2028, PCVX is forecast to generate $28,041,844,680 in revenue, with the lowest revenue forecast at $28,041,844,680 and the highest revenue forecast at $28,041,844,680.

What is PCVX's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: PCVX) forecast ROA is -26.98%, which is lower than the forecast US Biotechnology industry average of 36.43%.

What is PCVX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year PCVX price target, the average PCVX price target is $38.00, with the highest PCVX stock price forecast at $38.00 and the lowest PCVX stock price forecast at $38.00.

The Wall Street analyst predicted that Vaxcyte's share price could fall to $38.00 by Sep 12, 2026. The average Vaxcyte stock price prediction forecasts a potential downside of 11.32% from the current PCVX share price of $42.85.

What is PCVX's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: PCVX) Vaxcyte's current Earnings Per Share (EPS) is -$4.11. On average, analysts forecast that PCVX's EPS will be -$5.19 for 2025, with the lowest EPS forecast at -$5.96, and the highest EPS forecast at -$4.34. On average, analysts forecast that PCVX's EPS will be -$5.82 for 2026, with the lowest EPS forecast at -$7.28, and the highest EPS forecast at -$4.16. In 2027, PCVX's EPS is forecast to hit -$7.07 (min: -$7.07, max: -$7.07).

What is PCVX's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: PCVX) forecast ROE is -29.04%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.